Search details
1.
The receptor binding domain of SARS-CoV-2 Omicron subvariants targets Siglec-9 to decrease its immunogenicity by preventing macrophage phagocytosis.
Nat Immunol
; 25(4): 622-632, 2024 Apr.
Article
in English
| MEDLINE | ID: mdl-38454157
2.
Pam2CSK4-adjuvanted SARS-CoV-2 RBD nanoparticle vaccine induces robust humoral and cellular immune responses.
Front Immunol
; 13: 992062, 2022.
Article
in English
| MEDLINE | ID: mdl-36569949
3.
SARS-CoV-2 Omicron strain exhibits potent capabilities for immune evasion and viral entrance.
Signal Transduct Target Ther
; 6(1): 430, 2021 12 17.
Article
in English
| MEDLINE | ID: mdl-34921135
Results
1 -
3
de 3
1
Next >
>>